In conclusion,these fidings showed that miR-193b may function in the development of AD and exosomal miR-193b has potential as a novel,non-invasive,blood-based biomarker of MCI and DAT patients.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback